More affordable than ever, 3D printers are booming for personal, professional, and educational use. Here's everything to know before you buy one, along with the top models from our hands-on testing.

Sobi has completed the acquisition of AstraZeneca’s Synagis (palivizumab) for $1.5 billion in cash and shares, plus certain conditional payments. As part of the deal, first announced in August ...

Sanofi and Sobi's haemophilia partnership has been under competitive pressure from new therapies like Roche's antibody Hemlibra, so the two companies are hoping a new long-acting drug candidate ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

However, there are some difficulties in the traditional production of these muscles, as 2D muscle monolayers often peel… In the past few years, China’s status in the 3D printing industry has gone from ...

At close: April 4 at 5:29:50 PM GMT+2 ...

Please view our affiliate disclosure. In the rapidly evolving world of technology, artificial intelligence (AI) has been a game-changer, especially in the field of 3D object generation. AI-powered 3D ...